Acadia Healthcare Company Inc (ACHC) is Reiterated by UBS to Buy, Lowers Price Target to $ 55

Acadia Healthcare Company Inc (ACHC) was Reiterated by UBS to “Buy” while Lowering the Price Target of the company shares to $ 55 from a previous price target of $79 . UBS advised their investors in a research report released on Oct 19, 2016.

Many Wall Street Analysts have commented on Acadia Healthcare Company Inc. Shares were Reiterated by RBC Capital Mkts on Oct 19, 2016 to “Outperform” and Lowered the Price Target to $ 59 from a previous price target of $78 .Shares were Reiterated by RBC Capital Mkts on Aug 1, 2016 to “Outperform” and Lowered the Price Target to $ 78 from a previous price target of $86 .

On the company’s financial health, Acadia Healthcare Company Inc reported $0.73 EPS for the quarter, based on the information available during the earnings call on Jul 29, 2016. Analyst had a consensus estimate of $0.73. The company had revenue of $756.55 million for the quarter, compared to analysts expectations of $754.90 million. The company’s revenue was up 66.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.57 EPS.

Acadia Healthcare Company Inc closed down -1.18 points or -2.68% at $42.81 with 12,71,245 shares getting traded on Friday. Post opening the session at $44.3, the shares hit an intraday low of $42.69 and an intraday high of $44.3 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

In a different news, on Sep 16, 2016, Reeve B Waud (director) sold 1,360,977 shares at $49.30 per share price. According to the SEC, on Aug 17, 2016, David M. Duckworth (Chief Financial Officer) sold 16,670 shares at $54.33 per share price. On Aug 15, 2016, Ronald Morgan Fincher (Chief Operating Officer) sold 14,604 shares at $52.50 per share price, according to the Form-4 filing with the securities and exchange commission.

Acadia Healthcare Company Inc. is a provider of behavioral healthcare services. The Company develops and operates inpatient psychiatric facilities residential treatment centers group homes substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities. It operates in two segments: U.S. Facilities and U.K. Facilities. Its U.S. Facilities and services are classified into categories which includes acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services. In the United Kingdom it provides inpatient services through mental health hospitals and care homes. In addition to these services it also operates a U.K. division to provide EAP to organizations. The Company operated approximately 78 behavioral healthcare facilities with over 5800 beds in approximately 24 states the United Kingdom and Puerto Rico.

Acadia Healthcare Company Inc

Leave a Reply

Acadia Healthcare Company Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Acadia Healthcare Company Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.